[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BalaBioResearch BalaBio Research BalaBio Research posts on X about $srpt, $cort, $crnx, $rare the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1930394110906580992/interactions)  - X Week XXXXXX +651% ### Mentions: XX [#](/creator/twitter::1930394110906580992/posts_active)  ### Followers: XX [#](/creator/twitter::1930394110906580992/followers)  - X Week XX +132% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1930394110906580992/influencer_rank)  ### Social Influence [#](/creator/twitter::1930394110906580992/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% [finance](/list/finance) XXXXX% [cryptocurrencies](/list/cryptocurrencies) XX% **Social topic influence** [$srpt](/topic/$srpt) #171, [$cort](/topic/$cort) 13.33%, [$crnx](/topic/$crnx) 13.33%, [$rare](/topic/$rare) 10%, [$fold](/topic/$fold) 10%, [$bmrn](/topic/$bmrn) 10%, [$mreo](/topic/$mreo) 6.67%, [$abeo](/topic/$abeo) 6.67%, [af](/topic/af) 3.33%, [$500myr](/topic/$500myr) XXXX% **Top accounts mentioned or mentioned by** [@jeremyj0916](/creator/undefined) [@yachmod](/creator/undefined) [@biotech2k1](/creator/undefined) [@lcccc333](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [SuperRare (RARE)](/topic/$rare) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Synthetify (SNY)](/topic/$sny) [Biogen Inc (BIIB)](/topic/$biib) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Morgan Stanley (MS)](/topic/morgan-stanley) ### Top Social Posts [#](/creator/twitter::1930394110906580992/posts) --- Top posts by engagements in the last XX hours "$SRPT if true it is disgusting that management didn't disclose this death on the call yesterday. Praying for those affected. An activist investor is necessary management needs to be held accountable"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1946017820011016625) 2025-07-18 01:22:58 UTC XX followers, 1643 engagements "$CORT Relacorilant shrunk XX% of microadenomas in the GRACE study with only XX% increasing in size after treatment (low sample size)"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945150738872606876) 2025-07-15 15:57:29 UTC XX followers, XXX engagements "$SRPT Very interested in how much they can get from these programs. A big/medium size pharma interested in entering gene therapy may make a large upfront payment to sarepta for their entire LGMD portfolio"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945582157780369522) 2025-07-16 20:31:48 UTC XX followers, 2663 engagements "@yachmod AF is now saying the death was a month ago I can't believe this wasnt disclosed at any point"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1946021423140499853) 2025-07-18 01:37:17 UTC XX followers, XXX engagements "@Biotech2k1 I understand not liking Elevidys (I think its priced way too high for how mediocre it is for what it was designed to do) but this to me is too asymmetric for me to stay uninvested. (cont.)"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945940634776240372) 2025-07-17 20:16:15 UTC XX followers, XX engagements "$SRPT if they only need $500m/yr of elevidys revenue to stay profitable then they will have extremely strong FCF I don't see a world where they only dose XX people per quarter in 26/27"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945591058911375717) 2025-07-16 21:07:10 UTC XX followers, 1027 engagements "Highest conviction long positions going into 2H25: (In order) $CORT* Corcept Therapeutics $ABEO* Abeona $RARE / $MREO* Ultragenyx/Mereo $SRPT Sarepta $CRNX Crinetics $FOLD* Amicus $BMRN BioMarin *research report posted"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1940500962088755458) 2025-07-02 20:00:56 UTC XX followers, 1066 engagements "Crinetics Pharmaceuticals $CRNX An Endocrine Focused Biotech with an Incredible Research Platform and a Soon to Be Approved Blockbuster 1/2"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1941197728106807621) 2025-07-04 18:09:38 UTC XX followers, XXX engagements "$CRNX Palsonify is a nice name. I like the more simple ones 😁"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1944591902600200484) 2025-07-14 02:56:53 UTC XX followers, 3283 engagements "I think buying $SRPT in the 21s today makes much more sense than buying at XX yesterday. I was already very bullish yesterday"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945890146143854776) 2025-07-17 16:55:38 UTC XX followers, XXX engagements "$FOLD Hard to believe Amicus isn't an acquisition target at these prices. $SNY $BMRN make sense as possible targets though BMRN would need to leverage with debt. Unless they terribly botch their launches Amicus really should be an easy XX% to XXX% gain in the coming years"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1944861086592720998) 2025-07-14 20:46:31 UTC XX followers, XXX engagements "$CORT I would not be surprised if their MOMENTUM study shows a XX% rate of hypercortisolism in people with resistant hypertension"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945151583387287985) 2025-07-15 16:00:51 UTC XX followers, XXX engagements "$SRPT $BIIB Biogen should buy the entire LGMD portfolio for $1b XX% royalty. In X years it could completely transform their future. Someone's going to get this platform on fire sale and Biogen has needed promising products for years now"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945653730088522198) 2025-07-17 01:16:12 UTC XX followers, XXX engagements "@jeremyj0916 Yep it brings me such strong anger that there are people who spend their time at companies such as these knowingly dosing patients with often net negative drugs and giving them false hope. These people get rich off retail investors while simultaneously hurting the weakest"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1944883099692884217) 2025-07-14 22:13:59 UTC XX followers, XXX engagements "$CRNX Crinetics looks very cheap massive cash moat with a free pipeline. I may write about this in the coming weeks"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1938408965957702121) 2025-06-27 01:28:06 UTC XX followers, XXX engagements "$SRPT a patient has died of acute liver failure in a phase one limb girdle study"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1946013902522732770) 2025-07-18 01:07:24 UTC XX followers, XXX engagements "@Biotech2k1 I think if a different company had the PMOs LGMD platform and the ARWR assets with no Elevidys it would be worth 4b at least. IMO the balance sheet fear is overblown. (I hate the PMOs but they sell so whatever)"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945940950942986535) 2025-07-17 20:17:31 UTC XX followers, XX engagements "$CORT Relacorilant PR-Ovarian NDA I'm confident in approval due to stellar safety profile. Very interested to see the eventual pricing/other cancer indications"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1944771309713469718) 2025-07-14 14:49:46 UTC XX followers, XXX engagements "$SRPT Best case scenario Ambulatory stays on market with black box and is submitting new protocol to FDA for non-ambulatory. Elevedys Q2: 282m PMOs Q2: 231m My january $30C gonna have a great day tomr :D"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945578265420104112) 2025-07-16 20:16:20 UTC XX followers, XXX engagements "$CRSP Director George Simeon just bought 1million shares ($50million) over doubling his stake in the company to XXX million shares"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945958199317717501) 2025-07-17 21:26:03 UTC XX followers, XXX engagements "$RARE $MREO IA2 missed progressing to final analysis in Q4"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1943039569986715968) 2025-07-09 20:08:28 UTC XX followers, XXX engagements "$FOLD Morgan Stanley realized how grossly undervalued Amicus is today it always surprises me when the market reacts to analyst upgrades this strongly"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1945840134424850832) 2025-07-17 13:36:54 UTC XX followers, XXX engagements "$ABEO $RARE UX111 CRL Ultragenyx is claiming it is manufacturing related and not an issue of clinical data. RARE expects 2026 approval"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1943778047171154386) 2025-07-11 21:02:54 UTC XX followers, XXX engagements "Thinking about writing a report on $BMRN lmk if you all would be interested My model has it conservatively at $14b MC (30% above closing price) and I have a lop of confidence in their management to make good M&A choices as possible upside. Inozyme was a steal"  [@BalaBioResearch](/creator/x/BalaBioResearch) on [X](/post/tweet/1944864535178801161) 2025-07-14 21:00:13 UTC XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BalaBio Research posts on X about $srpt, $cort, $crnx, $rare the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXXX% finance XXXXX% cryptocurrencies XX%
Social topic influence $srpt #171, $cort 13.33%, $crnx 13.33%, $rare 10%, $fold 10%, $bmrn 10%, $mreo 6.67%, $abeo 6.67%, af 3.33%, $500myr XXXX%
Top accounts mentioned or mentioned by @jeremyj0916 @yachmod @biotech2k1 @lcccc333
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Corcept Therapeutics Inc. (CORT) Crinetics Pharmaceuticals, Inc. (CRNX) SuperRare (RARE) Amicus Therapeutics, Inc (FOLD) BioMarin Pharmaceutical, Inc. (BMRN) Synthetify (SNY) Biogen Inc (BIIB) CRISPR Therapeutics AG (CRSP) Morgan Stanley (MS)
Top posts by engagements in the last XX hours
"$SRPT if true it is disgusting that management didn't disclose this death on the call yesterday. Praying for those affected. An activist investor is necessary management needs to be held accountable" @BalaBioResearch on X 2025-07-18 01:22:58 UTC XX followers, 1643 engagements
"$CORT Relacorilant shrunk XX% of microadenomas in the GRACE study with only XX% increasing in size after treatment (low sample size)" @BalaBioResearch on X 2025-07-15 15:57:29 UTC XX followers, XXX engagements
"$SRPT Very interested in how much they can get from these programs. A big/medium size pharma interested in entering gene therapy may make a large upfront payment to sarepta for their entire LGMD portfolio" @BalaBioResearch on X 2025-07-16 20:31:48 UTC XX followers, 2663 engagements
"@yachmod AF is now saying the death was a month ago I can't believe this wasnt disclosed at any point" @BalaBioResearch on X 2025-07-18 01:37:17 UTC XX followers, XXX engagements
"@Biotech2k1 I understand not liking Elevidys (I think its priced way too high for how mediocre it is for what it was designed to do) but this to me is too asymmetric for me to stay uninvested. (cont.)" @BalaBioResearch on X 2025-07-17 20:16:15 UTC XX followers, XX engagements
"$SRPT if they only need $500m/yr of elevidys revenue to stay profitable then they will have extremely strong FCF I don't see a world where they only dose XX people per quarter in 26/27" @BalaBioResearch on X 2025-07-16 21:07:10 UTC XX followers, 1027 engagements
"Highest conviction long positions going into 2H25: (In order) $CORT* Corcept Therapeutics $ABEO* Abeona $RARE / $MREO* Ultragenyx/Mereo $SRPT Sarepta $CRNX Crinetics $FOLD* Amicus $BMRN BioMarin *research report posted" @BalaBioResearch on X 2025-07-02 20:00:56 UTC XX followers, 1066 engagements
"Crinetics Pharmaceuticals $CRNX An Endocrine Focused Biotech with an Incredible Research Platform and a Soon to Be Approved Blockbuster 1/2" @BalaBioResearch on X 2025-07-04 18:09:38 UTC XX followers, XXX engagements
"$CRNX Palsonify is a nice name. I like the more simple ones 😁" @BalaBioResearch on X 2025-07-14 02:56:53 UTC XX followers, 3283 engagements
"I think buying $SRPT in the 21s today makes much more sense than buying at XX yesterday. I was already very bullish yesterday" @BalaBioResearch on X 2025-07-17 16:55:38 UTC XX followers, XXX engagements
"$FOLD Hard to believe Amicus isn't an acquisition target at these prices. $SNY $BMRN make sense as possible targets though BMRN would need to leverage with debt. Unless they terribly botch their launches Amicus really should be an easy XX% to XXX% gain in the coming years" @BalaBioResearch on X 2025-07-14 20:46:31 UTC XX followers, XXX engagements
"$CORT I would not be surprised if their MOMENTUM study shows a XX% rate of hypercortisolism in people with resistant hypertension" @BalaBioResearch on X 2025-07-15 16:00:51 UTC XX followers, XXX engagements
"$SRPT $BIIB Biogen should buy the entire LGMD portfolio for $1b XX% royalty. In X years it could completely transform their future. Someone's going to get this platform on fire sale and Biogen has needed promising products for years now" @BalaBioResearch on X 2025-07-17 01:16:12 UTC XX followers, XXX engagements
"@jeremyj0916 Yep it brings me such strong anger that there are people who spend their time at companies such as these knowingly dosing patients with often net negative drugs and giving them false hope. These people get rich off retail investors while simultaneously hurting the weakest" @BalaBioResearch on X 2025-07-14 22:13:59 UTC XX followers, XXX engagements
"$CRNX Crinetics looks very cheap massive cash moat with a free pipeline. I may write about this in the coming weeks" @BalaBioResearch on X 2025-06-27 01:28:06 UTC XX followers, XXX engagements
"$SRPT a patient has died of acute liver failure in a phase one limb girdle study" @BalaBioResearch on X 2025-07-18 01:07:24 UTC XX followers, XXX engagements
"@Biotech2k1 I think if a different company had the PMOs LGMD platform and the ARWR assets with no Elevidys it would be worth 4b at least. IMO the balance sheet fear is overblown. (I hate the PMOs but they sell so whatever)" @BalaBioResearch on X 2025-07-17 20:17:31 UTC XX followers, XX engagements
"$CORT Relacorilant PR-Ovarian NDA I'm confident in approval due to stellar safety profile. Very interested to see the eventual pricing/other cancer indications" @BalaBioResearch on X 2025-07-14 14:49:46 UTC XX followers, XXX engagements
"$SRPT Best case scenario Ambulatory stays on market with black box and is submitting new protocol to FDA for non-ambulatory. Elevedys Q2: 282m PMOs Q2: 231m My january $30C gonna have a great day tomr :D" @BalaBioResearch on X 2025-07-16 20:16:20 UTC XX followers, XXX engagements
"$CRSP Director George Simeon just bought 1million shares ($50million) over doubling his stake in the company to XXX million shares" @BalaBioResearch on X 2025-07-17 21:26:03 UTC XX followers, XXX engagements
"$RARE $MREO IA2 missed progressing to final analysis in Q4" @BalaBioResearch on X 2025-07-09 20:08:28 UTC XX followers, XXX engagements
"$FOLD Morgan Stanley realized how grossly undervalued Amicus is today it always surprises me when the market reacts to analyst upgrades this strongly" @BalaBioResearch on X 2025-07-17 13:36:54 UTC XX followers, XXX engagements
"$ABEO $RARE UX111 CRL Ultragenyx is claiming it is manufacturing related and not an issue of clinical data. RARE expects 2026 approval" @BalaBioResearch on X 2025-07-11 21:02:54 UTC XX followers, XXX engagements
"Thinking about writing a report on $BMRN lmk if you all would be interested My model has it conservatively at $14b MC (30% above closing price) and I have a lop of confidence in their management to make good M&A choices as possible upside. Inozyme was a steal" @BalaBioResearch on X 2025-07-14 21:00:13 UTC XX followers, XXX engagements
/creator/twitter::BalaBioResearch